CULLINAN THERAPEUTICS INC (CGEM:NASDAQ)
$14.54 0.17 (1.183%)
Analysed CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) News Sources
Cullinan Therapeutics Shares Fall 6.3% After Phase 3 Zipalertinib Trial Results
14-09-2026
advfn.com
Cullinan Therapeutics (CGEM) Reports a Six-Month PFS Gain. Can it Justify Higher Toxicity?
17-09-2026
yahoo.com
Cullinan Therapeutics (CGEM) Could Be 50% Below Fair Value On Phase 3 Zipalertinib Data
24-09-2026
yahoo.com
Cullinan Therapeutics Highlights Fourth Quarter 2026 Milestones Across Immunology and Oncology T Cell Engager Portfolio
24-09-2026
yahoo.com
Cullinan Therapeutics Plans Q4 2026 Clinical Data Updates Across Three T Cell Engager Programs
24-09-2026
advfn.com
CGEM Stock Extends Losses After Cullinan Delays Arthritis Update To December — Zipalertinib Safety Worries Linger
24-09-2026
stocktwits.com
Cullinan Therapeutics (CGEM) Expects Three T Cell Engager Data Readouts In Q4 2026
26-09-2026
yahoo.com
Cullinan Therapeutics Eyes December Data Catalyst for CLN-978 and CLN-049
28-09-2026
marketbeat.com
Cullinan Therapeutics Announces First Patient Dosed in Planned Registrational Phase 2 Study of CLN-049 in Relapsed/Refractory Acute Myeloid Leukemia
08-10-2026
yahoo.com
Zipalertinib Demonstrates Clinically Meaningful Intracranial Antitumor Activity in Patients with NSCLC with EGFR Exon 20 Insertion or Uncommon EGFR Mutations and Active CNS Metastases
19-10-2026
yahoo.com
What is the current price of CULLINAN THERAPEUTICS INC (CGEM:NASDAQ)?
The current price of CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) is $14.54.
CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) absolute price change since previous trading day?
The absolute price change of CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) since the previous trading day is $0.17.
CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) percentage price change since previous trading day?
The percentage price change of CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) since the previous trading day is 1.183%.
What is the most recent average sentiment score for CULLINAN THERAPEUTICS INC (CGEM:NASDAQ)?
The most recent average sentiment score for CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for CULLINAN THERAPEUTICS INC (CGEM:NASDAQ)?
The most recent sentiment for CULLINAN THERAPEUTICS INC (CGEM:NASDAQ) is .
SEC-8K** Filing Available For CULLINAN THERAPEUTICS INC (CGEM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.